每经AI快讯，康方生物(09926.HK)涨超3%，截至发稿，涨3.83%，报121.9港元，成交额2.71亿港元。 （文章来源：每日经济新闻） ...

Core Insights - The event "2025 Shenzhen International High-Performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition" was held in Hong Kong, focusing on "Innovative Drugs and Devices, Collaborative Win-Win" [1] - Over 120 companies, universities, and research institutions participated, with more than 300 representatives attending [1] - The exhibition showcased the "hard power" of the Greater Bay Area's pharmaceutical and medical device industry, featuring advanced medical equipment and innovative pharmaceutical achievements [1] Group 1 - The event adopted a "conference + exhibition" model to explore cutting-edge technology trends and collaborative development initiatives [1] - It aimed to deepen cross-border cooperation between Shenzhen and Hong Kong in the pharmaceutical and medical device sectors, contributing to high-quality development in the Greater Bay Area [1] - Notable exhibits included advanced surgical robots and automated models for traditional Chinese medicine, highlighting the industrial vitality of both regions [1] Group 2 - Top experts from institutions like the Chinese Academy of Sciences and the U.S. National Academy of Inventors delivered keynote speeches on topics such as infrared fluorescence imaging and clinical applications of surgical robots [1] - The organizers expressed intentions to further integrate industrial resources and align with international standards to create a closed-loop ecosystem of "research-industry-capital" [1] - This initiative is expected to help the Greater Bay Area establish itself as a world-class hub for the pharmaceutical and medical device industries [1]

每经AI快讯，锅圈(02517.HK)涨超4%，截至发稿，涨4.07%，报10.5港元，成交额7247.94万港元。 （文章来源：每日经济新闻） ...

每经AI快讯，同源康医药-B(02410.HK)早盘一度涨超5%，截至发稿， 涨3.73%，报13.35港元，成交额 2154.6万港元。 （文章来源：每日经济新闻） ...

智通财经APP获悉，2025 年 12 月 11 日，亚洲领先的稳定币交易与支付平台OSL集团(00863)今日发布 接受美国联邦监管的美元稳定币USDGO，这是公司强化全球合规支付网络的重要举措。作为OSL集团 全球支付基础设施建设中的基石，USDGO将致力于加速构建支付生态的未来，提供更快捷、更具成本 效益的支付解决方案。 作为美国首家也是唯一一家受联邦监管的加密银行，Anchorage Digital将担任USDGO的发行方。OSL集 团为USDGO的品牌运营及分销方。 USDGO将采取多链策略，以确保在各大主流区块链生态系统中，实现最大程度的可访问性与互操作 性。此举使用户能够在自己首选的区块链网络上进行交易，并在安全保障与监管标准上保持一致。 Solana将成为部署USDGO的首条公链，未来还将陆续扩展至更多链上。 重要提示 USDGO的设计旨在符合《指导和建立美国稳定币国家创新法案》(GENIUS Act)的严格标准，并由包括 美国国债在内的优质流动资产提供1:1的储备支持。USDGO的发行方为首家也是唯一一家受美国联邦监 管的加密银行Anchorage Digital Bank。 OSL集团及其 ...

消息面上，据赛晶科技官微消息，近日，赛晶科技旗下子公司——浙江嘉善科能电力设备有限公司凭借 卓越的技术实力、可靠的产品质量及丰富的行业经验，成功中标 United Solar Polysilicon (FZC) SPC(联 合太阳能多晶硅(FZC)有限公司)阿曼年产10万吨高纯硅基材料项目的21KV滤波装置采购项目，为该海 外项目提供关键电力设备支持。 此次中标的21KV滤波装置，是保障项目电力系统稳定运行的关键设备，能够实现无功补偿及谐波抑制 等功能，确保生产过程中电力供应的高效与稳定。该装置严格遵循阿曼当地电力行业标准，结合项目所 在地炎热沙漠气候特点，在绝缘性能、耐温性、抗风沙及防紫外线等方面进行了专项优化设计，可实现 8000小时/年的稳定运行，完全满足项目长期、高效的生产需求。 智通财经APP获悉，赛晶科技(00580)涨超3%，截至发稿，涨3.47%，报2.09港元，成交额625.86万港 元。 ...

该适应症的获批主要基于CULMINATE-1研究，显示库莫西利联合氟维司群较氟维司群取得了显著的中 位无进展生存期(PFS)改善，大幅降低了HR+/HER2-晚期乳腺癌疾病进展或死亡风险。 乳腺癌已成为全球及中国女性群体中的"第一大癌种"，HR+/HER2-乳腺癌是最主要的亚型。对于晚期 HR+乳腺癌，国内外指南目前均推荐CDK4/6抑制剂作为治疗选择，但CDK4/6抑制剂本身的耐药问题、 骨髓抑制问题也亟待解决。 作为新一代CDK2/4/6抑制剂，库莫西利独特分子结构设计：既能精准靶向抑制CDK4，又能显著增强对 CDK2的结合能力，同时对CDK6的抑制作用较弱，能有效降低骨髓抑制的用药风险。临床前数据显 示，库莫西利对CDK2、CDK4的抑制活性显著优于传统CDK4/6抑制剂。 库莫西利此次获批主要基于CULMINATE-1研究，该研究充分验证了产品的疗效与安全性。安全性方 面，库莫西利联合氟维司群组治疗相关不良事件(TRAEs)多为1-2级，较传统CDK4/6抑制剂具有更低的 骨髓抑制风险，为长期治疗的依从性提供了有效保障。 有券商在近期报告中将库莫西利列为潜在的"重磅炸弹"药物，仅在中国的峰值销售额便 ...

Group 1 - The core viewpoint of the article highlights that China Energy Engineering Corporation (referred to as "the company") has received an "AAAsti" rating for its technology innovation perpetual corporate bonds, indicating strong creditworthiness [1] - The company possesses a competitive advantage across the entire energy and power design and construction industry chain, with continuous growth in new contract amounts and a favorable owner structure, demonstrating strong project undertaking capabilities [1] - The company has a high degree of business diversification, with related businesses contributing positively to profitability and strong operational cash flow, showcasing significant financial flexibility [1] Group 2 - The company was established with a registered capital of 21.6 billion yuan, approved by the State-owned Assets Supervision and Administration Commission of the State Council [2] - The company went public in December 2015 on the Hong Kong Stock Exchange, increasing its total share capital to 30.02 billion yuan [2] - In September 2021, the company completed a share swap merger with its subsidiary, China Gezhouba Group Co., Ltd., achieving overall listing on the A-share market [2] - The company's main business focuses on engineering construction and surveying design consulting, with total operating revenue of 436.713 billion yuan in 2024 [2]

Core Viewpoint - The Hong Kong restaurant sector is experiencing active performance, with notable gains in stocks such as Shanghai Xiaonan Guo, Jiumaojiu, and others, driven by positive signals from the Central Economic Work Conference regarding consumer spending recovery [1] Group 1: Market Performance - Shanghai Xiaonan Guo increased by over 7% - Jiumaojiu rose nearly 5% - Other companies like Yum China, Nayuki, and Haidilao saw gains of nearly 3%, while Xiabuxiabu increased by 2.5% [1] Group 2: Policy Impact - The Central Economic Work Conference held on December 10-11 emphasized the importance of domestic demand and building a strong domestic market - Key policies include implementing actions to boost consumption, formulating plans to increase income for urban and rural residents, and removing unreasonable restrictions in the consumption sector [1] Group 3: Industry Outlook - Analysts suggest that the positive signals from the conference pave the way for the continued recovery of restaurant consumption - The overall sector is expected to benefit from a mild recovery in the consumer environment, indicating potential for valuation recovery [1] - Galaxy Securities highlights the need to focus on the medium to long-term goals of consumption outlined in the 14th Five-Year Plan, with short-term attention on specific policies related to consumption expected to be implemented by 2026 [1]

花旗发布研报称，下调华润电力(00806)目标价11.6%，从21.5港元降至19港元，评级从"买入"降至"中 性"。花旗表示，下调对燃煤电价的预期，2026年现预测将降低3.5%，主要原因是在广东所签署的合 同。同时，燃煤电厂的单位燃料成本上升。因此将该公司2026年纯利预测下调8.3%，2027年纯利预测 下调7.9%。 该行将对该公司的评级降至"中性"而非"沽出"，是因为其2025年预期股息率为6.4%，虽然可以接受，但 仍低于其同行华能国际（600011）电力(00902)的8.5%，派息比率40%，也低于华能的50%对于2026年的 预测，该行更倾向于选择中国电力设备供应商而不是运营商，因为后者可能因中国没有电力短缺而面临 市场电价下降带来的利润率下降。 ...